Gemita 1000mg/62.5mg Injection
By Gemita
Rx
1 Injection in a Vial

Composition
Gemcitabine(1000mg) + Mannitol(62.5mg)

Manufacturer - Fresenius Kabi India Pvt Ltd
Fresenius Kabi AG"‹ , Else-Kröner-Straße 1 "‹ , 61352 Bad Homburg , Germany

Expires on or after
April, 2026

liver
Safety Advice - Liver Limited information is available regarding the use of Gemita 1000mg/62.5mg Injection in individuals with liver disease. It is advised to consult your doctor before using this medication if you have any liver-related issues. Seeking medical guidance is crucial to ensure the safe and appropriate use of Gemita 1000mg/62.5mg Injection in such cases.

kidney
Gemita 1000mg/62.5mg Injection is likely safe for patients with kidney disease. Current data indicates no need for dose adjustment. Always consult your doctor for proper guidance.

alcohol
Gemita 1000mg/62.5mg Injection can lead to increased drowsiness when consumed with alcohol.

driving
Gemita 1000mg/62.5mg Injection can reduce alertness, impact vision, and induce drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Gemita 1000mg/62.5mg Injection is not recommended during pregnancy due to potential risks to the developing baby. Your doctor may only prescribe it in critical situations after considering the benefits and risks. Consult your doctor for advice.

breastfeeding
Gemita 1000mg/62.5mg Injection is not recommended for use during breastfeeding as it may pose a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | - |
₹6131
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025